当前位置: 首页 >> 检索结果
101. Prophylaxis Against Atrial Fibrillation After General Thoracic Surgery: Trial Sequential Analysis and Network Meta-Analysis.
作者: Bing-Cheng Zhao.;Tong-Yi Huang.;Qi-Wen Deng.;Wei-Feng Liu.;Jian Liu.;Wen-Tao Deng.;Ke-Xuan Liu.;Cai Li.
来源: Chest. 2017年151卷1期149-159页
Postoperative atrial fibrillation/flutter (POAF) is associated with significant morbidity and mortality after general thoracic surgery, but the need for and the best agent for prophylaxis remains obscure.
102. Comparative Effectiveness and Safety of Preoperative Lung Localization for Pulmonary Nodules: A Systematic Review and Meta-analysis.
作者: Chul Hwan Park.;Kyunghwa Han.;Jin Hur.;Sang Min Lee.;Ji Won Lee.;Sung Ho Hwang.;Jae Seung Seo.;Kye Ho Lee.;Woocheol Kwon.;Tae Hoon Kim.;Byoung Wook Choi.
来源: Chest. 2017年151卷2期316-328页
An optimal method of preoperative localization for pulmonary nodules has yet to be established. This systematic review and meta-analysis aimed to compare the success and complication rates associated with three pulmonary nodule localization methods for video-assisted thoracoscopic surgery (VATS): hook-wire localization, microcoil localization, and lipiodol localization.
103. Prevalence and Localization of Pulmonary Embolism in Unexplained Acute Exacerbations of COPD: A Systematic Review and Meta-analysis.
作者: Floor E Aleva.;Lucas W L M Voets.;Sami O Simons.;Quirijn de Mast.;André J A M van der Ven.;Yvonne F Heijdra.
来源: Chest. 2017年151卷3期544-554页
Patients with COPD experience episodes of increased inflammation, so-called acute exacerbations of COPD (AE-COPD). In 30% of AE-COPD cases, no clear cause is found. Since there is well-known cross talk between inflammation and thrombosis, the objectives of this study were to determine the prevalence, embolus localization, clinical relevance, and clinical markers of pulmonary embolism (PE) in unexplained AE-COPD.
104. Pulmonary Rehabilitation as a Mechanism to Reduce Hospitalizations for Acute Exacerbations of COPD: A Systematic Review and Meta-Analysis.
作者: Elizabeth Moore.;Thomas Palmer.;Roger Newson.;Azeem Majeed.;Jennifer K Quint.;Michael A Soljak.
来源: Chest. 2016年150卷4期837-859页
Acute exacerbation of COPD (AECOPD) has a significant impact on health-care use, including physician visits and hospitalizations. Previous studies and reviews have shown that pulmonary rehabilitation (PR) has many benefits, but the effect on hospitalizations for AECOPD is inconclusive.
105. Risks of Venous Thromboembolism After Cesarean Sections: A Meta-Analysis.
作者: Marc Blondon.;Alessandro Casini.;Kara K Hoppe.;Françoise Boehlen.;Marc Righini.;Nicholas L Smith.
来源: Chest. 2016年150卷3期572-96页
Cesarean sections (CS) are believed to be associated with greater risks of postpartum VTE. Our objective was to systematically review the evidence on this association and on the absolute risk of VTE following CS.
106. Efficacy and Safety of Pulmonary Arterial Hypertension-specific Therapy in Pulmonary Arterial Hypertension: A Meta-analysis of Randomized Controlled Trials.
作者: Huan-Long Liu.;Xue-Yan Chen.;Jie-Ru Li.;Su-Wen Su.;Tao Ding.;Chen-Xia Shi.;Yun-Fa Jiang.;Zhong-Ning Zhu.
来源: Chest. 2016年150卷2期353-66页
Previous meta-analyses of pulmonary arterial hypertension (PAH)-specific therapy for PAH pooled PAH-specific combination therapy and monotherapy. This flaw may threaten the authenticity of their findings.
107. A Systematic Review With Meta-Analysis of Dual Bronchodilation With LAMA/LABA for the Treatment of Stable COPD.
作者: Luigino Calzetta.;Paola Rogliani.;Maria Gabriella Matera.;Mario Cazzola.
来源: Chest. 2016年149卷5期1181-96页
The wide availability of long-acting muscarinic antagonist (LAMA)/long-acting β2-agonist (LABA) fixed-dose combinations (FDCs) in the absence of head-to-head comparative pragmatic trials makes it difficult to choose which combination should be used. Therefore, we carried out a systematic review with meta-analysis that incorporated the data from trials lasting at least 3 months to evaluate the effectiveness of LAMA/LABA FDCs for COPD treatment.
108. The Presence of Diffuse Alveolar Damage on Open Lung Biopsy Is Associated With Mortality in Patients With Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis.
作者: Pablo Cardinal-Fernández.;Ednan K Bajwa.;Andrea Dominguez-Calvo.;Justo M Menéndez.;Laurent Papazian.;B Taylor Thompson.
来源: Chest. 2016年149卷5期1155-64页
Diffuse alveolar damage (DAD) is considered the histologic hallmark of ARDS although DAD is absent in approximately half of patients with ARDS. The clinical implications of having the syndrome of ARDS with DAD vs other histologic patterns is unknown. To address this question, we conducted a meta-analysis of lung biopsy series for patients with ARDS.
109. Drug Treatment of Idiopathic Pulmonary Fibrosis: Systematic Review and Network Meta-Analysis.
作者: William J Canestaro.;Sara H Forrester.;Ganesh Raghu.;Lawrence Ho.;Beth E Devine.
来源: Chest. 2016年149卷3期756-66页
Idiopathic pulmonary fibrosis (IPF) is a form of chronic progressive fibrosing interstitial lung disease of unknown origin. Recently, nintedanib and pirfenidone demonstrated efficacy in slowing disease progression and were approved by the US Food and Drug Administration. Although numerous treatments have been evaluated in IPF, none have shown significant decreases in mortality. The objective of this study was to identify all pharmacologic treatments evaluated for IPF and analyze their efficacy via Bayesian network meta-analysis and pairwise indirect treatment comparisons. This review did not evaluate the effect of steroid therapy.
110. Efficacy of EGFR Tyrosine Kinase Inhibitors in the Adjuvant Treatment for Operable Non-small Cell Lung Cancer by a Meta-Analysis.
作者: Qingyuan Huang.;Jinhui Li.;Yihua Sun.;Rui Wang.;Xinghua Cheng.;Haiquan Chen.
来源: Chest. 2016年149卷6期1384-92页
The role of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in the adjuvant treatment of non-small cell lung cancer (NSCLC) has not been well-established. Our meta-analysis aimed to determine whether the administration of EGFR-TKIs could improve the outcomes of patients with NSCLC undergoing complete resection.
111. The COPD Assessment Test: What Do We Know So Far?: A Systematic Review and Meta-Analysis About Clinical Outcomes Prediction and Classification of Patients Into GOLD Stages.
作者: Manuela Karloh.;Anamaria Fleig Mayer.;Rosemeri Maurici.;Marcia M M Pizzichini.;Paul W Jones.;Emilio Pizzichini.
来源: Chest. 2016年149卷2期413-425页
The COPD Assessment Test (CAT) was developed as a simple instrument to assess health status in patients with COPD. This study aimed to systematically review the determinants of the CAT score, its ability to predict clinical outcomes, and the agreement between CAT (≥ 10) and the modified Medical Research Council scale (mMRC ≥ 2) to categorize patients into the new Global Initiative for Chronic Obstructive Lung Disease classification system.
112. Efficacy and Safety of Corticosteroids for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis.
作者: You-Dong Wan.;Tong-Wen Sun.;Zi-Qi Liu.;Shu-Guang Zhang.;Le-Xin Wang.;Quan-Cheng Kan.
来源: Chest. 2016年149卷1期209-19页
Corticosteroids are an option in the treatment of community-acquired pneumonia (CAP). However, the benefits and adverse effects of corticosteroids, especially in severe CAP, have not been well assessed.
113. Ultrasound Guidance Facilitates Radial Artery Catheterization: A Meta-analysis With Trial Sequential Analysis of Randomized Controlled Trials.
作者: Wan-Jie Gu.;Xiang-Dong Wu.;Fei Wang.;Zheng-Liang Ma.;Xiao-Ping Gu.
来源: Chest. 2016年149卷1期166-79页
Potential benefits and possible risks associated with ultrasound guidance compared with traditional palpation for radial artery catheterization are not fully understood.
114. Stroke, Major Bleeding, and Mortality Outcomes in Warfarin Users With Atrial Fibrillation and Chronic Kidney Disease: A Meta-Analysis of Observational Studies.
作者: Khagendra Dahal.;Sumit Kunwar.;Jharendra Rijal.;Peter Schulman.;Juyong Lee.
来源: Chest. 2016年149卷4期951-9页
The use of warfarin in patients with atrial fibrillation (AF) and chronic kidney disease (CKD) can be problematic because of increased bleeding risk. We performed a systematic review and meta-analysis of observational studies that evaluated the use of warfarin in patients with AF and CKD to evaluate the risks of ischemic stroke/thromboembolism, major bleeding, and mortality.
115. Risk Stratification of Patients With Acute Symptomatic Pulmonary Embolism Based on Presence or Absence of Lower Extremity DVT: Systematic Review and Meta-analysis.
作者: Cecilia Becattini.;Alexander T Cohen.;Giancarlo Agnelli.;Luke Howard.;Borja Castejón.;Javier Trujillo-Santos.;Manuel Monreal.;Arnaud Perrier.;Roger D Yusen.;David Jiménez.
来源: Chest. 2016年149卷1期192-200页
For patients diagnosed with acute pulmonary embolism (PE), the prognostic significance of concomitant DVT lacks clarity.
116. Short-term Exposure to Ambient Fine Particulate Matter Increases Hospitalizations and Mortality in COPD: A Systematic Review and Meta-analysis.
作者: Man-Hui Li.;Li-Chao Fan.;Bei Mao.;Jia-Wei Yang.;Augustine M K Choi.;Wei-Jun Cao.;Jin-Fu Xu.
来源: Chest. 2016年149卷2期447-458页
Many epidemiologic studies have documented variable relationships between ambient particulate matter (PM) and COPD hospitalizations and mortality in cities worldwide.
117. The Volume-Outcome Relationship in Critical Care: A Systematic Review and Meta-analysis.
作者: Yên-Lan Nguyen.;David J Wallace.;Youri Yordanov.;Ludovic Trinquart.;Josefin Blomkvist.;Derek C Angus.;Jeremy M Kahn.;Philippe Ravaud.;Bertrand Guidet.
来源: Chest. 2015年148卷1期79-92页
The purpose of this study was to systematically review the research on volume and outcome relationships in critical care.
118. Treatment Options for Pediatric Patent Ductus Arteriosus: Systematic Review and Meta-analysis.
作者: Jennifer Y Lam.;Steven R Lopushinsky.;Irene W Y Ma.;Frank Dicke.;Mary E Brindle.
来源: Chest. 2015年148卷3期784-793页
Patent ductus arteriosus (PDA) in the nonpremature pediatric patient is currently treated by surgical ligation or catheter occlusion. There is no clear superiority of one technique over the other. This meta-analysis compares the clinical outcomes of the two treatment options for PDA.
119. Meta-analysis of Randomized Controlled Trials of Genotype-Guided vs Standard Dosing of Warfarin.
作者: Khagendra Dahal.;Sharan P Sharma.;Erik Fung.;Juyong Lee.;Jason H Moore.;John N Unterborn.;Scott M Williams.
来源: Chest. 2015年148卷3期701-710页
Warfarin is a widely prescribed anticoagulant, and its effect depends on various patient factors including genotypes. Randomized controlled trials (RCTs) comparing genotype-guided dosing (GD) of warfarin with standard dosing have shown mixed efficacy and safety outcomes. We performed a meta-analysis of all published RCTs comparing GD vs standard dosing in adult patients with various indications of warfarin use.
120. The use of inhaled prostaglandins in patients with ARDS: a systematic review and meta-analysis.
作者: Brian M Fuller.;Nicholas M Mohr.;Lee Skrupky.;Susan Fowler.;Marin H Kollef.;Christopher R Carpenter.
来源: Chest. 2015年147卷6期1510-1522页
This study aimed to determine whether inhaled prostaglandins are associated with improvement in pulmonary physiology or mortality in patients with ARDS and assess adverse effects.
|